Article
Concise Review: Rational Use of Mesenchymal Stem Cells in the Treatment of Ischemic Heart Disease
17 Apr 2018
Abstract excerpt
The capacity of stem and progenitor cells to stimulate cardiac regeneration has been studied for almost 20 years, with very promising preclinical data and mixed clinical results. Several cell types have been studied, identified by their cell surface markers, differentiation capacity and their secreted growth factors. Bone marrow derived mesenchymal stem cells (MSCs) have been found to have potent regenerative...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
